UT Southwestern Medical Center researchers have identified two lipids that work together with a quintessential protein known ...

The central question is no longer whether we can innovate, but whether innovation can truly reach patients in time.

Diamyd Medical Announces Finalization Of Database For Interim Analysis In Phase 3 DIAGNODE-3 Trial. STOCKHOLM, Feb. 24, 2026 /PRNewswire/ -- The clinical database has been finalized for the pre-specif ...

People on GLP-1 drugs like Ozempic aren't just losing weight — they're spontaneously seeking out exercise, and neuroscientists believe the drugs are recalibrating the brain's reward system in ways ...

The clinical database has been finalized for the pre-specified interim efficacy analysis in Diamyd Medical's ongoing pivotal Phase 3 trial (DIAGNODE-3) evaluating retogatein (rhGAD65) in individuals w ...

Disorders of the central nervous system (CNS), including neurodegenerative, ischemic, neuroinflammatory, and traumatic conditions, remain leading causes of ...

Lionheart Health, Inc. announces a USPTO Letter of Allowance for its patented bioelectric technology designed to upregulate GDF10 and complementary regenerative proteins, supporting investigational ...

In an analysis of therapeutic interventions following the failure of chimeric antigen receptor (CAR) T-cell therapy, Rahul ...

Seedless fruits are highly valued for their superior edible quality and consumer appeal, yet the biological mechanisms that allow fruits to develop ...

Tau hyperphosphorylation is linked to neurodegeneration in tauopathies including Alzheimer’s disease. Tau binds microtubules cooperatively to form cohesive tau envelopes, which are thought to control ...